Related Experiment Video
Updated: Feb 21, 2026
Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
Screening Performance of Placental Growth Factor for the Prediction of Low Birth Weight and Adverse Intrapartum and
Larissa N Bligh1, Ristan M Greer, Sailesh Kumar
1Mater Research Institute - University of Queensland, South Brisbane, QLD, and Faculty of Medicine and Biomedical Sciences, University of Queensland, Herston, QLD, Australia.
Introduction:
Fetuses who fail to reach their genetic growth potential are thought to have sub-optimal placental function. Low placental growth factor (PlGF) levels have been shown to be predictive of placentally mediated conditions, such as pre-eclampsia or fetal growth restriction. We investigated the screening performance of PlGF for the prediction of low birth weight (<10th centile for gestation) and adverse intrapartum and neonatal outcomes in apparently low-risk term pregnancies.
Materials And Methods:
Maternal PlGF levels were measured fortnightly in a blinded, prospective, observational study from 36 weeks of pregnancy. Women and clinicians were blinded to PlGF results, and pregnancies were managed according to local policies and guidelines. Intrapartum and neonatal outcomes were recorded. PlGF was analysed for association with, and predictive capacity for, low birth weight, caesarean section for intrapartum fetal compromise (CS-IFC) and adverse neonatal outcomes.
Results:
A total of 438 women were included in the final analysis. Lower PlGF levels were associated with low birth weight, CS-IFC and adverse neonatal outcome. For a false-positive rate of 10 and 20%, respectively, the corresponding sensitivities were 9.7-11.1% and 22.2-26.8%.
Conclusion:
As a sole predictor for low birth weight, CS-IFC and adverse neonatal outcome, PlGF was poor as a test.
